Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC

April 22, 2002

CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo

April 22, 2002

All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant

April 22, 2002

Lead Androgenics compound blocks androgen receptor activation at an early step

April 22, 2002

Novogen's phenoxodiol stabilizes tumor growth with minimal toxicity

April 19, 2002

Irofulven trial in refractory pancreatic cancer discontinued

April 19, 2002

Isoliquiritigenin shows potential as a prostate cancer preventive

April 19, 2002

Palonosetron effective for the treatment of chemotherapy-induced nausea and vomiting

April 19, 2002

TNP-470 and docetaxel as combination therapy for transitional cell carcinoma of the bladder

April 19, 2002

Novel class of potent cytotoxic tubulin-interacting agents identified by Zentaris

April 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...